Literature DB >> 25429913

Charcot-Marie-Tooth disease: frequency of genetic subtypes in a Southern Italy population.

Fiore Manganelli1, Stefano Tozza, Chiara Pisciotta, Emilia Bellone, Rosa Iodice, Maria Nolano, Alessandro Geroldi, Simona Capponi, Paola Mandich, Lucio Santoro.   

Abstract

The objective of this study is to assess the genetic distribution of Charcot-Marie-Tooth (CMT) disease in Campania, a region of Southern Italy. We analyzed a cohort of 197 index cases and reported the type and frequency of mutations for the whole CMT population and for each electrophysiological group (CMT1, CMT2, and hereditary neuropathy with susceptibility to pressure palsies [HNPP]) and for familial and isolated CMT cases. Genetic diagnosis was achieved in 148 patients (75.1%) with a higher success rate in HNPP and CMT1 than CMT2. Only four genes (PMP22, GJB1, MPZ, and GDAP1) accounted for 92% of all genetically confirmed CMT cases. In CMT1, PMP22 duplication was the most common mutation while the second gene in order of frequency was MPZ in familial and SH3TC2 in isolated cases. In CMT2, GJB1 was the most frequent mutated gene and GJB1 with GDAP1 accounted for almost 3/4 of genetically defined CMT2 patients. The first gene in order of frequency was GJB1 in familial and GDAP1 in isolated cases. In HNPP, the majority of patients harbored the PMP22 gene deletion. The novelty of our data is the relatively high frequency of SH3TC2 and GDAP1 mutations in demyelinating and axonal forms, respectively. These epidemiological data can help in panel design for our patients' population.
© 2014 Peripheral Nerve Society.

Entities:  

Keywords:  Charcot-Marie-Tooth disease; epidemiology; genetics; hereditary neuropathy

Mesh:

Substances:

Year:  2014        PMID: 25429913     DOI: 10.1111/jns.12092

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  26 in total

Review 1.  Kinesins: Motor Proteins as Novel Target for the Treatment of Chronic Pain.

Authors:  P A Shantanu; Dilip Sharma; Monika Sharma; Shivani Vaidya; Kuhu Sharma; Kiran Kalia; Yuan-Xiang Tao; Amit Shard; Vinod Tiwari
Journal:  Mol Neurobiol       Date:  2018-09-13       Impact factor: 5.590

2.  Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).

Authors:  Giuseppe Piscosquito; Paola Saveri; Stefania Magri; Claudia Ciano; Claudia Gandioli; Michela Morbin; Daniela D Bella; Isabella Moroni; Franco Taroni; Davide Pareyson
Journal:  J Peripher Nerv Syst       Date:  2016-09       Impact factor: 3.494

3.  Whole exome sequencing reveals a broader variant spectrum of Charcot-Marie-Tooth disease type 2.

Authors:  Shan Lin; Liu-Qing Xu; Guo-Rong Xu; Ling-Ling Guo; Bi-Juan Lin; Wan-Jin Chen; Ning Wang; Yi Lin; Jin He
Journal:  Neurogenetics       Date:  2019-12-12       Impact factor: 2.660

4.  Charcot-Marie-Tooth disease: genetic subtypes in the Sardinian population.

Authors:  Lorena Lorefice; Maria Rita Murru; Giancarlo Coghe; Giuseppe Fenu; Daniela Corongiu; Jessica Frau; Stefania Tranquilli; Paolo Tacconi; Alessandro Vannelli; Giovanni Marrosu; Elena Mamusa; Eleonora Cocco; Maria Giovanna Marrosu
Journal:  Neurol Sci       Date:  2017-03-13       Impact factor: 3.307

5.  Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E.

Authors:  Chiara Pisciotta; Yunhong Bai; Kathryn M Brennan; Xingyao Wu; Tiffany Grider; Shawna Feely; Suola Wang; Steven Moore; Carly Siskind; Michael Gonzalez; Stephan Zuchner; Michael E Shy
Journal:  Neurology       Date:  2015-06-24       Impact factor: 9.910

6.  Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2.

Authors:  Jun-Hui Yuan; Akihiro Hashiguchi; Yuji Okamoto; Akiko Yoshimura; Masahiro Ando; Kazutaka Shiomi; Kayoko Saito; Makoto Takahashi; Keiko Ichinose; Takuma Ohmichi; Kazushi Ichikawa; Adachi Tadashi; Hiroshi Takigawa; Hidehiro Shibayama; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

7.  Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.

Authors:  Pukar Singh Pakhrin; Yongzhi Xie; Zhengmao Hu; Xiaobo Li; Lei Liu; Shunxiang Huang; Binghao Wang; Zihan Yang; Jiejun Zhang; Xin Liu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

8.  Charcot-Marie-Tooth disease: New insights from skin biopsy.

Authors:  Fiore Manganelli; Maria Nolano; Chiara Pisciotta; Vincenzo Provitera; Gian M Fabrizi; Tiziana Cavallaro; Annamaria Stancanelli; Giuseppe Caporaso; Michael E Shy; Lucio Santoro
Journal:  Neurology       Date:  2015-09-11       Impact factor: 9.910

9.  Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.

Authors:  Alejandro Horga; Matilde Laurà; Zane Jaunmuktane; Nivedita U Jerath; Michael A Gonzalez; James M Polke; Roy Poh; Julian C Blake; Yo-Tsen Liu; Sarah Wiethoff; Conceição Bettencourt; Michael Pt Lunn; Hadi Manji; Michael G Hanna; Henry Houlden; Sebastian Brandner; Stephan Züchner; Michael Shy; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-13       Impact factor: 10.154

10.  Genetic and clinical spectrums in Korean Charcot-Marie-Tooth disease patients with myelin protein zero mutations.

Authors:  Hye Jin Kim; Soo Hyun Nam; Hye Mi Kwon; Si On Lim; Jae Hong Park; Hyun Su Kim; Sang Beom Kim; Kyung Suk Lee; Ji Eun Lee; Byung-Ok Choi; Ki Wha Chung
Journal:  Mol Genet Genomic Med       Date:  2021-04-06       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.